Results 111 to 120 of about 3,629 (180)

Idiopaattinen epilepsia koirilla ja epilepsian kohtaustyyppien luokittelu sekä epilepsian tyypillinen kliininen kuva kolmella koirarodulla : pitkäkarvainen pyreneittenpaimenkoira, schipperke ja kääpiöpinseri [PDF]

open access: yes, 2013
Epileptinen kohtaus voidaan luokitella idiopaattiseksi, sekundaariseksi (symptomaattiseksi), luultavasti sekundaariseksi (kryptogeeniseksi) ja reaktiiviseksi. Epilepsia voidaan todeta idiopaattiseksi, jos taustalla ei todeta rakenteellista vikaa aivoissa,
Pilve, Penita
core  

Additional file 3: of A double-blinded randomised dietary supplement crossover trial design to investigate the short-term influence of medium chain fatty acid (MCT) supplement on canine idiopathic epilepsy: study protocol

open access: yes, 2019
Study Visit Questionnaire. Designed study questionnaire using five scientific validated questionnaire covering cognition, ADHD related behaviour, appetite and quality of life; Canine Behavioral Assessment & Research Questionnaire (C-BARQ, Attention deficit hyperactivity disorder Questionnaire (ADHD) [67], The canine cognitive dysfunction rating ...
Berk, Benjamin   +9 more
openaire   +1 more source

Primaire idiopatische epilepsie bij de hond: praktische aanpak en een update van de behandeling. [PDF]

open access: yes, 2011
Primaire idiopathische epilepsie is een frequent voorkomende neurologische aandoening bij de hond. De diagnose wordt gesteld door alle andere oorzaken van epilepsie uit te sluiten.
Bhatti, Sofie   +2 more
core   +1 more source

Canine idiopathic epilepsy as a natural animal model for human epilepsy: a metabolic perspective beyond the brain

open access: yes
Abstract Emerging evidence indicates that epilepsy extends beyond the brain, involving systemic metabolic, immune, and microbiome perturbations that shape neuronal excitability and treatment response. Canine idiopathic epilepsy (CE) offers a naturally occurring, genetically diverse model with strong electrophysiological, pharmacological,
Giulia Cabri   +6 more
openaire   +1 more source

Additional file 1: of A double-blinded randomised dietary supplement crossover trial design to investigate the short-term influence of medium chain fatty acid (MCT) supplement on canine idiopathic epilepsy: study protocol

open access: yes, 2019
Pre-Study Questionnaire. Online survey designed for initial registration for the trial and to assess potential suitability of test candidate. (PDF 346 kb)
Berk, Benjamin   +9 more
openaire   +1 more source

Additional file 2: of A double-blinded randomised dietary supplement crossover trial design to investigate the short-term influence of medium chain fatty acid (MCT) supplement on canine idiopathic epilepsy: study protocol

open access: yes, 2019
SPIRIT Item Checklist (PDF 108 kb)
Berk, Benjamin   +9 more
openaire   +1 more source

Survival in feline epilepsy: the long and short of it [PDF]

open access: yes, 2017
Arrol   +22 more
core   +2 more sources

Additional file 4: of A double-blinded randomised dietary supplement crossover trial design to investigate the short-term influence of medium chain fatty acid (MCT) supplement on canine idiopathic epilepsy: study protocol

open access: yes, 2019
Table S1. Study Variables: For each on-site study visit, relevant data are collected and monitored by the investigator on the clinical progress of each patient. Collected data will be later converted into predefined study variable assessing MCT as DS in comparison to the control DS.
Berk, Benjamin   +9 more
openaire   +1 more source

Idiopaattinen epilepsia belgianpaimenkoirilla : perinnöllisyys ja tyypillinen kohtauskuva rotumuunnoksittain [PDF]

open access: yes, 2013
Epilepsia on koiran yleisin neurologinen sairaus ja belgianpaimenkoirarodulla uskotaan olevan selvästi korkeampi riski sairastua epilepsiaan kuin koirapopulaatiossa yleisesti.
Ismail, Bilgin
core  

2025 ACVIM Forum Research Abstract Program

open access: yes
Journal of Veterinary Internal Medicine, Volume 39, Issue 6, November/December 2025.
wiley   +1 more source

Home - About - Disclaimer - Privacy